Lunit Unveils New AI-Powered Tumor Microenvironment Insights in Lung Cancer at WCLC 2026
recent articles
After thorough testing, and internal clinical validation, Herlev University Hospital selects Visiopharm’s ONCOtopix™ Dx – a platform for computer assisted quantitative diagnostic immunohistochemistry (IHC) and In-Situ Hybridization...
Source: Pittsburgh Business Times UPMC/GE Healthcare-owned digital pathology firm in growth mode Digital pathology company Omnyx LLC is planning to hire 10 people this year, a 12 percent increase in its workforce, as the Strip...
microDimensions announced new versions of its digital pathology applications Outspace™ and Voloom®. The updates address some of the most important features requested by its customers and are available to all clients with an active...
Visiopharm continues to make news this year with appointment of Patrik Dahlén to its Board of Directors as Chairman. Today Visiopharm announces that Patrik Dahlén, previously the CEO of Dako, has joined the Visiopharm Board of Directors as...
SAN DIEGO, March 2, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA and circulating tumor cells (CTCs), today announced that...
Courtesy of Vitali Khvatkov, Founder and CEO, Smart Imaging Technologies via LinkedIn: Google Chrome, the preferred browsers of 49% of Internet users will deprecate in 2015 support for some plugins causing hangs and crashes, including...
